The gut microbiota, a key to understanding the health implications of micro(nano)plastics and their biodegradation
| Autor: | Cristina Jiménez‐Arroyo, Alba Tamargo, Natalia Molinero, M. Victoria Moreno‐Arribas |
|---|---|
| Přispěvatelé: | Ministerio de Ciencia, Innovación y Universidades (España), Ministerio de Ciencia e Innovación (España), European Commission, Agencia Estatal de Investigación (España), Comunidad de Madrid |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Microbial Biotechnology. 16:34-53 |
| ISSN: | 1751-7915 |
| DOI: | 10.1111/1751-7915.14182 |
| Popis: | The effects of plastic debris on the environment and plant, animal, and human health are a global challenge, with micro(nano)plastics (MNPs) being the main focus. MNPs are found so often in the food chain that they are provoking an increase in human intake. They have been detected in most categories of consumed foods, drinking water, and even human feces. Therefore, oral ingestion becomes the main source of exposure to MNPs, and the gastrointestinal tract, primarily the gut, constantly interacts with these small particles. The consequences of human exposure to MNPs remain unclear. However, current in vivo studies and in vitro gastrointestinal tract models have shown that MNPs of several types and sizes impact gut intestinal bacteria, affecting gut homeostasis. The typical microbiome signature of MNP ingestion is often associated with dysbiosis and loss of resilience, leads to frequent pathogen outbreaks, and local and systemic metabolic disorders. Moreover, the small micro- and nano-plastic particles found in animal tissues with accumulated evidence of microbial degradation of plastics/MNPs by bacteria and insect gut microbiota raise the issue of whether human gut bacteria make key contributions to the bio-transformation of ingested MNPs. Here, we discuss these issues and unveil the complex interplay between MNPs and the human gut microbiome. Therefore, the elucidation of the biological consequences of this interaction on both host and microbiota is undoubtedly challenging. It is expected that microbial biotechnology and microbiome research could help decipher the extent to which gut microorganisms diversify and MNP-determinant species, mechanisms, and enzymatic systems, as well as become important to understand our response to MNP exposure and provide background information to inspire future holistic studies. The work in progress in our laboratory is partially supported by the Spanish Ministry of Science and Innovation (Spain), grant number PID2019-108851RB-C21, ALIBIRD-CM 2020 P2018/BAA-4343 (Community of Madrid) and by the European Union's Horizon 2020 Research and Innovation 772 program, under the Grant Agreement number 965367 (PlasticsFatE). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|